China SXT Pharmaceuticals, Inc.
SXTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001723980
No open-market purchases or sales by China SXT Pharmaceuticals, Inc. insiders were filed in the last 90 days; 3 institutions reported holding it in 13F filings for Q2 2026, worth $6 in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding China SXT Pharmaceuticals, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 4 | 5 | +1 |
| Shares | 44.5K | 86.2K | +41.6K (+93.6%) |
| Value | $78.0K | $66.0K | −$12.0K (−15.4%) |
New holders (3)
Institutions that held China SXT Pharmaceuticals, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 45,685 | $35.0K | 0.00% |
| HRT Financial LP | 10,870 | $8.00K | 0.00% |
| UBS Group AG | 7,725 | $6.00K | 0.00% |
Sold out (2)
Institutions that held China SXT Pharmaceuticals, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Virtu Financial LLC | 14,868 | $26.0K |
| Tevis Investment Management | 13 | $0 |